Progress and Challenges of Immune Checkpoint Inhibitor-Induced Hypophysitis

Immune checkpoint inhibitors (ICIs) are a new type of antitumor drug which can achieve antitumor goals by blocking the binding of immune checkpoints to their ligands, thereby enhancing the activity of T cells. Meanwhile, ICIs block the binding of immune checkpoints to their ligands, disrupting the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Piaohong, Li, Jianwei, Tan, Huiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219051/
https://www.ncbi.nlm.nih.gov/pubmed/37240574
http://dx.doi.org/10.3390/jcm12103468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219051/
https://www.ncbi.nlm.nih.gov/pubmed/37240574
http://dx.doi.org/10.3390/jcm12103468

Ejemplares similares